Trader consensus favoring "No" at 88% stems from the rarity of pandemics—historically occurring every few decades—and the absence of any novel pathogen with sustained human-to-human transmission poised for global spread in 2026. WHO and CDC surveillance networks, bolstered post-COVID, show no elevated signals; recent H5N1 avian flu cases in the U.S. remain sporadic and mild, with no evidence of efficient airborne spread among humans, while mpox clade Ib outbreaks have been contained regionally. Models estimate annual pandemic odds below 3%, aligning with market-implied 12% "Yes," though traders discount projections amid improved vaccine platforms and early detection systems. Key watchpoints include 2025-2026 flu seasons and zoonotic spillovers, but current conditions justify skepticism.